These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104 [TBL] [Abstract][Full Text] [Related]
4. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding. Becker TM; Rizos H; Kefford RF; Mann GJ Clin Cancer Res; 2001 Oct; 7(10):3282-8. PubMed ID: 11595726 [TBL] [Abstract][Full Text] [Related]
5. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16. Wick ST; Dubay MM; Imanil I; Brizuela L Oncogene; 1995 Nov; 11(10):2013-9. PubMed ID: 7478520 [TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Phelps DE; Xiong Y Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177 [TBL] [Abstract][Full Text] [Related]
9. Lack of germline CDK6 mutations in familial melanoma. Shennan MG; Badin AC; Walsh S; Summers A; From L; McKenzie M; Goldstein AM; Tucker MA; Hogg D; Lassam N Oncogene; 2000 Mar; 19(14):1849-52. PubMed ID: 10777219 [TBL] [Abstract][Full Text] [Related]
10. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6. Noh SJ; Li Y; Xiong Y; Guan KL Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200 [TBL] [Abstract][Full Text] [Related]
11. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834 [TBL] [Abstract][Full Text] [Related]
12. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Timmermann S; Hinds PW; Münger K Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082 [TBL] [Abstract][Full Text] [Related]
13. p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells. Welcker M; Lukas J; Strauss M; Bartek J Cancer Res; 1998 Nov; 58(22):5053-6. PubMed ID: 9823309 [TBL] [Abstract][Full Text] [Related]
14. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule. Fåhraeus R; Laín S; Ball KL; Lane DP Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]